Skip to main content

Institutional intelligence for Infosys Ltd.

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters13.82%
  • FII27.09%
  • Mutual Funds23.00%
  • DII (ex-MF)19.96%
  • Retail & others16.13%
  • 1% Club 6.71%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Mutual Funds

Domestic mutual funds & UTI

23.00%5 named
HolderStakeSharesValue (₹ Cr)
4.92%18,40,57,994
4.37%16,32,66,157
1.89%7,06,07,911
1.73%6,46,77,781
1.13%4,21,61,076

FII / FPI

Foreign portfolio investors

27.09%2 named
HolderStakeSharesValue (₹ Cr)
1.33%4,98,72,777
1.26%4,72,40,496

Promoters

Promoter & promoter group

13.82%5 named
HolderStakeSharesValue (₹ Cr)
2.55%9,53,57,000
1.63%6,08,12,892
1.09%4,07,89,562
1.04%3,89,57,096
1.03%3,85,79,304

DII (other)

Insurance, banks, AIF, other domestic institutions

19.96%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as LIC11.73%43,87,75,372

Retail & others

Holders below 1% disclosure threshold and public non-institutions

16.13%

SEBI requires naming only shareholders with ≥1% stake. The remaining 16.13% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

6.71%3 named
HolderStakeSharesValue (₹ Cr)
3.20%11,97,48,645
2.20%8,23,65,727
1.31%4,89,03,820

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.